Sickle Cell Disease: An Opportunity for Palliative Care Across the Life Span

Nursing Clinics of North America

Volumn 45, Issue 3, 2010, Pages 375-397

  Wilkie, Diana J ^a   Johnson, Bonnye ^b   Mack, A Kyle ^c   Labotka, Richard ^b   Molokie, Robert E ^b,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Advance care planning; Bereavement; Grief; Pain; Palliative care; Sickle cell; Symptoms

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; BEREAVEMENT; DISEASE MANAGEMENT; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PSYCHOLOGICAL ASPECT; REVIEW; SICKLE CELL ANEMIA; THEORETICAL MODEL; ANALGESIA; ANEMIA, SICKLE CELL; PROCEDURES; PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADULT; ADVANCE CARE PLANNING; ANEMIA, SICKLE CELL; BEREAVEMENT; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PAIN; PALLIATIVE CARE; PAIN MANAGEMENT;

EID: 77956166152     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2010.03.003     Document Type: Review

References (95)

1. Center TSCI Sickle cell information-clinician summary. The Georgia Comprehensive Sickle Cell Center at Grady Health System Available at:, Accessed September 13, 2009. http://www.scinfo.org/prod05.htm.
2. Platt O.S., Brambilla D.J., Rosse W.F., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994, 330(23):1639-1644.
3. Heitkemper M.M., Shaver J.F. Nursing research opportunities in enteral nutrition. Nurs Clin North Am 1989, 24(2):415-426.
4. Mitchell P.H., Gallucci B., Fought S.G. Perspectives on human response to health and illness. Nurs Outlook 1991, 39(4):154-157.
5. Ruland C.M., Moore S.M. Theory construction based on standards of care: a proposed theory of the peaceful end of life. Nurs Outlook 1998, 46:169-175.
6. Widger K.A., Wilkins K. What are the key components of quality perinatal and pediatric end-of-life care? A literature review. J Palliat Care 2004, 20(2):105-112.
7. Emanuel E.J., Emanuel L.L. The promise of a good death. Lancet 1998, 351:sII21-sII29.
8. Approaching death: improving care at the end of life 1997, National Academy Press, Washington, DC. M.J. Field, C.K. Cassel (Eds.).
9. When children die: improving palliative and end-of-life care for children and their families 2003, The National Academies Press, Washington, DC. M.J. Field, R.E. Behrman (Eds.).
10. Forum NQ A national framework and preferred practices for palliative and hospice care quality 2006, National Quality Forum, Washington, DC.
11. Stroebe M.S., Hansson R.O., Stroebe W., et al. Introduction: concepts and issues in contemporary research on bereavement. Handbook of bereavement research 2001, American Psychological Association, Washington, DC. M.S. Stroebe, R.O. Hansson, W. Stroebe (Eds.).
12. Schut H., Stroebe M.S. Interventions to enhance adaptation to bereavement. J Palliat Med 2005, 8(Suppl 1):S140-S147.
13. Eckman JR, Platt AF. Problem oriented management of sickle syndromes; 1997. Available at: Accessed April 14, 2010. http://www.scinfo.org/prod04.htm.
14. Gallo A.M., Knafl K.A., Angst D.B. Information management in families who have a child with a genetic condition. J Pediatr Nurs 2009, 24(3):194-204.
15. Gallo AM, Wilkie DJ, Suarez ML, et al. Focus group findings about reproductive health decisions in people with sickle cell disease or trait. West J Nurs Res, in press.
16. Griffin M.F. Improving sickle cell disease newborn notification and follow-up services in North Texas Available at:, Accessed April 14, 2010. http://www.sicklecelldisease.net/index.php?option=com_content&task=view&id=83&Itemid=54.
17. Becker C, Clark E, DeSpelder LA, et al. A call to action: an IWG charter for a public health approach to dying, death, and loss, in review.
18. Beider S. An ethical argument for integrated palliative care. Evid Based Complement Alternat Med 2005, 2(2):227-231.
19. Anghelescu D.L., Oakes L., Hinds P.S. Palliative care and pediatrics. Anesthesiol Clin 2006, 24(1):145-161. ix.
20. Thomas V.J., Cohn T. Communication skills and cultural awareness courses for healthcare professionals who care for patients with sickle cell disease. J Adv Nurs 2006, 53(4):480-488.
21. Wilkie D.J., Brown M.A., Corless I., et al. Toolkit for nursing excellence at end of life transition for nurse educators (TNEEL-NE) 2001, Version 1.0, University of Illinois Chicago College of Nursing, Chicago.
22. Herrick J.B. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Intern Med 1910, 6:517-521.
23. Scott R.B. Health care priority and sickle cell anemia. JAMA 1970, 214(4):731-734.
24. Quinn C.T., Rogers Z.R., Buchanan G.R. Survival of children with sickle cell disease. Blood 2004, 103(11):4023-4027.
25. Falletta J.M., Woods G.M., Verter J.I., et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. J Pediatr 1995, 127(5):685-690.
26. Gaston M.H., Verter J.I., Woods G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986, 314(25):1593-1599.
27. Marcinak J.F., Frank A.L., Labotka R.L., et al. Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in 3- to 17-month-old infants with sickle cell diseases. J Pediatr 1991, 118(1):69-71.
28. Schoendorf K.C., Adams W.G., Kiely J.L., et al. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics 1994, 93(4):663-668.
29. Halasa N.B., Shankar S.M., Talbot T.R., et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2007, 44(11):1428-1433.
30. Cunningham G. Mortality among children with sickle cell disease identified by newborn screening during 1990-1994-California, Illinois and New York. MMWR Morb Mortal Wkly Rep 1998, 47(9):169-172.
31. Yanni E., Grosse S.D., Yang Q., et al. Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr 2009, 154(4):541-545.
32. Adams R.J., McKie V.C., Hsu L., et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339(1):5-11.
33. Fullerton H.J., Adams R.J., Zhao S., et al. Declining stroke rates in Californian children with sickle cell disease. Blood 2004, 104(2):336-339.
34. Ballas S.K. Pain management of sickle cell disease. Hematol Oncol Clin North Am 2005, 19(5):785-802. v.
35. Vichinsky E.P., Neumayr L.D., Earles A.N., et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000, 342(25):1855-1865.
36. The management of sickle cell disease. NIH publication no. 02-2117; 2002. Available at: Accessed April 14, 2010. http://www.nhlbi.nih.gov/health/prof/blood/sickle/sc_mngt.pdf.
37. Ohene-Frempong K., Weiner S.J., Sleeper L.A., et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91(1):288-294.
38. Switzer J.A., Hess D.C., Nichols F.T., et al. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006, 5(6):501-512.
39. Adams R.J., Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005, 353(26):2769-2778.
40. Kushner J.P., Porter J.P., Olivieri N.F. Secondary iron overload. Hematology Am Soc Hematol Educ Program 2001, 47-61.
41. Hindmarsh P.C., Brozovic M., Brook C.G., et al. Incidence of overt and covert neurological damage in children with sickle cell disease. Postgrad Med J 1987, 63(743):751-753.
42. Moser F.G., Miller S.T., Bello J.A., et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol 1996, 17(5):965-972.
43. Steen R.G., Emudianughe T., Hankins G.M., et al. Brain imaging findings in pediatric patients with sickle cell disease. Radiology 2003, 228(1):216-225.
44. Miller S.T., Macklin E.A., Pegelow C.H., et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001, 139(3):385-390.
45. Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med 1990, 150(3):501-504.
46. Platt O.S., Rosenstock W., Espeland M.A. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 1984, 311(1):7-12.
47. Al-Rimawi H., Jallad S. Sport participation in adolescents with sickle cell disease. Pediatr Endocrinol Rev 2008, 6(Suppl 1):214-216.
48. Britto M.T., Garrett J.M., Dugliss M.A., et al. Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. Pediatrics 1998, 101(2):250-256.
49. Kinney T.R., Ware R.E. The adolescent with sickle cell anemia. Hematol Oncol Clin North Am 1996, 10(6):1255-1264.
50. Bryant R., Walsh T. Transition of the chronically ill youth with hemoglobinopathy to adult health care: an integrative review of the literature. J Pediatr Health Care 2009, 23(1):37-48.
51. Eckman J.R. Leg ulcers in sickle cell disease. Hematol Oncol Clin North Am 1996, 10(6):1333-1344.
52. Aguilar C., Vichinsky E., Neumayr L. Bone and joint disease in sickle cell disease. Hematol Oncol Clin North Am 2005, 19(5):929-941. viii.
53. Smith J.A. Bone disorders in sickle cell disease. Hematol Oncol Clin North Am 1996, 10(6):1345-1356.
54. Charache S. Eye disease in sickling disorders. Hematol Oncol Clin North Am 1996, 10(6):1357-1362.
55. Downes S.M., Hambleton I.R., Chuang E.L., et al. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology 2005, 112(11):1869-1875.
56. Emerson G.G., Lutty G.A. Effects of sickle cell disease on the eye: clinical features and treatment. Hematol Oncol Clin North Am 2005, 19(5):957-973. ix.
57. Williams C.I., Shaffer E.A. Gallstone disease: current therapeutic practice. Curr Treat Options Gastroenterol 2008, 11(2):71-77.
58. Rogers Z.R. Priapism in sickle cell disease. Hematol Oncol Clin North Am 2005, 19(5):917-928. viii.
59. Fowler J.E., Koshy M., Strub M., et al. Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol 1991, 145(1):65-68.
60. Hassell K. Pregnancy and sickle cell disease. Hematol Oncol Clin North Am 2005, 19(5):903-916. vii,viii.
61. Sunshine H.R., Hofrichter J., Eaton W.A. Requirement for therapeutic inhibition of sickle haemoglobin gelation. Nature 1978, 275(5677):238-240.
62. Charache S., Terrin M.L., Moore R.D., et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995, 332(20):1317-1322.
63. Steinberg M.H., Barton F., Castro O., et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003, 289(13):1645-1651.
64. Darbari D.S., Kple-Faget P., Kwagyan J., et al. Circumstances of death in adult sickle cell disease patients. Am J Hematol 2006, 81(11):858-863.
65. Herrick J.B. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. Yale J Biol Med 2001, 74(3):179-184.
66. Watson J. The significance of the paucity of sickle cells in newborn Negro infants. Am J Med Sci 1948, 215(4):419-423.
67. Brown M.J., Weatherall D.J., Clegg J.B., et al. Benign sickle-cell anaemia. Br J Haematol 1972, 22(5):635.
68. Benjamin L. Pain management in sickle cell disease: palliative care begins at birth?. Hematology Am Soc Hematol Educ Program 2008, 466-474.
69. Morris C.R. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program 2008, 177-185.
70. Platt O.S., Thorington B.D., Brambilla D.J., et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991, 325(1):11-16.
71. Franck L.S., Treadwell M., Jacob E., et al. Assessment of sickle cell pain in children and young adults using the Adolescent Pediatric Pain Tool. J Pain Symptom Manage 2002, 23(2):114-120.
72. Jacob E., Beyer J.E., Miaskowski C., et al. Are there phases to the vaso-occlusive painful episode in sickle cell disease?. J Pain Symptom Manage 2005, 29(4):392-400.
73. Jacob E., Hesselgrave J., Sambuco G., et al. Variations in pain, sleep, and activity during hospitalization in children with cancer. J Pediatr Oncol Nurs 2007, 24(4):208-219.
74. Dampier C., Ely B., Brodecki D., et al. Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. J Pain 2002, 3(6):461-470.
75. Smith W.R., Penberthy L.T., Bovbjerg V.E., et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008, 148(2):94-101.
76. Wilkie D.J., Judge M.K., Berry D.L., et al. Usability of a computerized PAINReportIt in the general public with pain and people with cancer pain. J Pain Symptom Manage 2003, 25(3):213-224.
77. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1975, 1:277-299.
78. Wilkie D.J., Molokie R., Boyd-Seal D., et al. Patient-reported outcomes: nociceptive and neuropathic pain and pain barriers in adult outpatients with sickle cell disease. J Natl Med Assoc 2010, 102(1):18-27.
79. Treede R.D., Jensen T.S., Campbell J.N., et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70(18):1630-1635.
80. Schwartz L.A., Radcliffe J., Barakat L.P. Associates of school absenteeism in adolescents with sickle cell disease. Pediatr Blood Cancer 2009, 52(1):92-96.
81. Ballas S.K. Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells. Am J Hematol 1991, 36(2):122-130.
82. Alexander N., Higgs D., Dover G., et al. Are there clinical phenotypes of homozygous sickle cell disease?. Br J Haematol 2004, 126(4):606-611.
83. Taylor J.G., Nolan V.G., Mendelsohn L., et al. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 2008, 3(5):e2095.
84. Pack-Mabien A., Labbe E., Herbert D., et al. Nurses' attitudes and practices in sickle cell pain management. Appl Nurs Res 2001, 14(4):187-192.
85. Shapiro B.S., Benjamin L.J., Payne R., et al. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage 1997, 14(3):168-174.
86. Elander J., Lusher J., Bevan D., et al. Pain management and symptoms of substance dependence among patients with sickle cell disease. Soc Sci Med 2003, 57(9):1683-1696.
87. Martin J.J., Moore G.P. Pearls, pitfalls, and updates for pain management. Emerg Med Clin North Am 1997, 15(2):399-415.
88. Tanabe P., Myers R., Zosel A., et al. Emergency department management of acute pain episodes in sickle cell disease. Acad Emerg Med 2007, 14(5):419-425.
89. Benjamin L.J., Swinson G.I., Nagel R.L. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood 2000, 95(4):1130-1136.
90. Wright J., Bareford D., Wright C., et al. Day case management of sickle pain: 3 years experience in a UK sickle cell unit. Br J Haematol 2004, 126(6):878-880.
91. Ware M.A., Hambleton I., Ochaya I., et al. Day-care management of sickle cell painful crisis in Jamaica: a model applicable elsewhere?. Br J Haematol 1999, 104(1):93-96.
92. Raphael J.L., Kamdar A., Beavers M.B., et al. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital. Pediatr Blood Cancer 2008, 51(1):82-85.
93. Wright K., Adeosum O. Barriers to effective pain management in sickle cell disease. Br J Nurs 2009, 18(3):158-161.
94. McClain B.C., Kain Z.N. Pediatric palliative care: a novel approach to children with sickle cell disease. Pediatrics 2007, 119(3):612-614.
95. Zunin L.M., Zunin H.S. The art of condolence 1991, Harper Collins, New York.